Accordingly, our results indicate that the upregulation of EphA2–ephrinA1 promotes the destabilization of the endothelial–epithelial barrier and immune cell adhesion, suggesting that the inhibition of EphA2 and ephrinA1 could serve as a potential treatment for intestinal inflammation induced by IR. This evidence concerns the gene EPHA2 and inflammatory response.